Integrated Diagnostics Holdings plc (LON:IDHC)

Market Cap	167.62M
Revenue (ttm)	78.23M
Net Income (ttm)	13.46M
Shares Out	581.33M
EPS (ttm)	0.02
PE Ratio	12.85
Forward PE	10.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,228
Average Volume	317,057
Open	0.370
Previous Close	0.370
Day's Range	0.360 - 0.369
52-Week Range	0.275 - 0.540
Beta	0.44
RSI	41.41
Earnings Date	Apr 3, 2025

About LON:IDHC

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography – computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,692
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2023, LON:IDHC's revenue was 4.12 billion, an increase of 14.35% compared to the previous year's 3.61 billion. Earnings were 510.30 million, a decrease of -5.69%.

Financial numbers in EGP